Metabolic surgery and obesity related comorbidities

REFERENCE

Whitlock G, Lewington S, Sherliker P, Clarke R, Emberson J, Halsey J, et al. Body-mass index and cause-specific mortality in 900000 adults: Collaborative analyses of 57 prospective stu-dies. Prospective Study Collaboration. Lancet 2009; 373(9669): 1083−96.

Blüher M. Adipose tissue dysfunction contributes to obesity re-lated metabolic diseases. Best Pract Res Clin Endocrinol Me-tab 2013; 27(2): 163−77.

Sumarac-Dumanovic M, Stevanovic D, Ljubic A, Jorga J, Simic M, Stamenkovic-Pejkovic D, et al. Increased activity of interleukin-23/interleukin-17 proinflammatory axis in obese women. Int J Obes (Lond) 2009; 33(1): 151−6.

Polovina S. Endokrinološki aspekti lečenja gojaznosti. Acta Cli-nica 2014; 14(3): 88−93. (Serbian)

Albaugh VL, Flynn CR, Tamboli RA, Abumrad NN. Recent ad-vances in metabolic and bariatric surgery. F1000Res 2016; 5. pii: F1000 Faculty Rev-978.

Rubino F. Bariatric surgery: Effects on glucose homeostasis. Curr Opin Clin Nutr Metab Care 2006; 9(4): 497−507.

Currie CJ, Peters JR, Tynan A, Evans M, Heine RJ, Bracco OL, et al. Survival as a function of HbA1c in people with type 2 dia-betes: A retrospective cohort study. Lancet 2010; 375(9713): 481−9.

Ramachandran A, Snehalatha C, Shetty AS, Nanditha A. Trends in prevalence of diabetes in Asian countries. World J Diabetes 2012; 3(6): 110−7.

Polovina S, Micić D. Effects of dietary regiment on metabolic parameters in obese patients with impaired glucose tolerance. Med Pregl 2010; 63(7−8): 465−9. (Serbian)

Wadden TA, Neiberg RH, Wing RR, Clark JM, Delahanty LM, Hill JO. Look AHEAD Research Group . Four-year weight losses in the Look AHEAD study: Factors associated with long-term success. Obesity (Silver) 2011; 19(10): 1987−98.

Bjelović M, Babić T, Špica B, Gunjić D, Veselinović M, Polovina S. Gastric stimula-tion to treat the Type 2 diabetes: Results on week 16. Vojnosanit Pregl 2016; (In Press)

Pories WJ, Macdonald KG, Flickinger EG, Dohm GL, Sinha MK, Barakat HA, et al. Is type II diabetes mellitus (NIDDM) a sur-gical disease? Ann Surg 1992; 215(6): 633−43.

Buchwald H, Estok R, Fahrbach K, Banel D, Jensen MD, Pories WJ, et al. Weight and type 2 diabetes after bariatric surgery: Systematic review and meta-analysis. Am J Med 2009; 122(3): 248−56.

Sjöström L, Lindroos AK, Peltonen M, Torgerson J, Bouchard C, Carlsson B, et al. Lifestyle, diabetes, and cardi-ovascular risk factors 10 years after bariatric surgery. N Engl J Med 2004; 351(26): 2683−93.

Schauer PR, Bhatt DL, Kirwan JP, Wolski K, Brethauer SA, Nava-neethan SD, et al. STAMPEDE investigation group. Bariatric surgery versus intensive medical therapy for diabetes-3-year outcomes. N Engl J Med 2014; 370(21): 2002−13.

Cho YM. A gut feeling to cure diabetes: Potential mechanisms of diabetes remission after bariatric surgery. Diabetes Metab J 2014; 38(6): 406−15.

Penney NC, Kinross JM, Newton RC, Purkayastha S. The role of bile acids in reduc-ing the metabolic complications of obesity after bariatric surgery: A systematic review. Int J Obes (Lond) 2015; 39(11): 1565−74.

Tremaroli V, Karlsson F, Werling M, Stahlman M, Kovatcheva-Datchary P, Olbers T, et al. Roux-en-Y gastric bypass and vertical banded gastroplasty induce long-term changes on the human gut microbiome contributing to fat mass regulation. Cell Metab 2015; 22(2): 228−38.

Ugale S, Gupta N, Modi KD, Kota SK, Satwalekar V, Naik V, et al. Prediction of remission after metabolic surgery using a nov-el scoring system in type 2 diabetes: A retrospective cohort study. J Diabetes Metab Disord 2014; 13(1): 89.

Busetto L. Timing of bariatric surgery in people with obesity and diabetes. Ann Translat Med 2015; 3(7): 94.

Rubino F, Nathan D, Eckel RH, Schauer RP, Alberti GM, Zimmet PZ, et al. Metabolic Surgery in the Treatment Algorithm for Type 2 Diabetes: A Joint Statement by International Diabetes Organizations. Diabetes Care 2016; 39(6): 861−77.

Schuppan D, Schattenberg JM. Non-alcoholic steatohepatitis: Pa-thogenesis and novel therapeutic approaches. J Gastroenterol Hepatol 2013; 28(Suppl 1): 68−76.

Arias-Loste MT, Ranchal I, Romero-Gómez M, Crespo J. Irisin, a link among fatty liver disease, physical inactivity and insulin resistance. Int J Mol Sci 2014; 15(12): 23163−78.

Sasaki A, Nitta H, Otsuka K, Umemura A, Baba S, Obuchi T, et al. Bariatric surgery and non-alcoholic fatty liver disease: Cur-rent and potential future treatments. Front Endocrinol (Lau-sanne) 2014; 5: 164.

Aguilar-Olivos NE, Almeda-Valdes P, Aguilar-Salinas CA, Uribe M, Méndez-Sánchez N. The role of bariatric surgery in the man-agement of nonalcoholic fatty liver disease and metabolic syn-drome. Metabolism 2016; 65(8): 1196−207.

Goossens N, Hoshida Y, Song WM, Jung M, Morel P, Nakagawa S, et al. Nonalcoholic Steatohepatitis is Associated with Increased Mortality in Obese Patients Undergoing Bariatric Surgery. Clin Gastroenterol Hepatol 2016; 14(11): 1619−28.

Ribeireiro T, Swain J, Sarr M, Kandrick M, Que F, Sanderson S, et al. NAFLD and insulin resistance do not increase the risk of postoperative complications among patients undergoing baria-tric surgery--a prospective analysis. Obes Surg 2011; 21(3): 310−5.

Sugerman HJ, de Maria EJ, Felton WL 3rd, Nakatsuka M, Sismanis A. Increased intraabdominal pressure and cardiac filling pressures in obesity-associated pseudotu-mor cerebri. Neurology 1997; 49(2): 507−11.

Yaggi HK, Concato J, Kernan WN, Lichtman JH, Brass LM, Mohsenin V. Obstructive sleep apnea a risk for stroke and death. N Engl J Med 2005; 353(19): 2034−41.

Frezza EE, Shebani KO, Robertson J, Wachtel MS. Morbid obesity causes chronic increase of intraabdominal pressure. Dig Dis Sci 2007; 52(4): 1038−41.

da Araújo LS, Fernandes JF, Klein MR, Sanjuliani AF. Obstruc-tive sleep apnea is independently associated with inflammation and insulin resistance, but not with blood pressure, plasma ca-techolamines, and endothelial function in obese subjects. Nu-trition 2015; 31(11−12): 1351−7.

Micić D, Šumarac-Dumanović M, Šušić V, Pejković D, Polovina S. Sleep and metabolic disorders. Glas Srp Akad Nauka Med 2011; 51: 5−25. (Serbian)

de Raaff CA, Coblijn UK, Ravesloot MJ, de Vries N, de Lan-gede KES, van Wagensveld BA. Persistent moderate or severe obstructive sleep apnea after laparoscopic Roux-en-Y gastric bypass: which patients?. Surg Obes Relat Dis 2016; pii: S1550-7289(16)00104-0.

Rasheid S, Banasiak M, Gallagher SF, Lipska A, Kaba S, Ventimiglia D, et al. Gastric bypass is an effective treatment for obstructive sleep apnea in patients with clinically significant obesity. Obes Surg 2003; 13(1): 58−61.

Quintas-Neves M, Preto J, Drummond M. Assessment of bariatric surgery efficacy on Obstructive Sleep Apnea (OSA). Rev Port Pneumol (2006) 2016; pii: S2173−5115(16)30046-X.

Vlasova M, Purhonen AK, Jarvelin MR, Rodilla E, Pascual J, Herzig KH. Role of adipokines in obesity-associated hypertension. Acta Physiol (Oxf) 2010; 200(2): 107−27.

Lee SK, Heo Y, Park JM, Kim YJ, Kim SM, do Park J, et al. Roux-en-Y Gastric Bypass vs. Sleeve Gastrectomy vs. Gastric Banding: The First Multicenter Retrospective Comparative Cohort Study in Obese Korean Patients. Yonsei Med J 2016; 57(4): 956−62.

Adami GF, Papadia F, Carlini F, Murelli F, Scopinaro N. Effect of biliopancreatic di-version on hypertension in severely obese patients. Hypertens Res 2005; 28(2): 119−23.

Schiavon CA, Drager LF, Bortolotto LA, Amodeo C, Ikeoka D, Berwanger O, et al. The Role of Metabolic Surgery on Blood Pressure Control. Curr Atheroscler Rep 2016; 18(8): 50.

Boström AE, Mwinyi J, Voisin S, Wu W, Schultes B, Zhang K, et al. Longitudinal ge-nome-wide methylation study of Roux-en-Y gastric bypass patients reveals novel CpG sites associated with essential hypertension. BMC Med Genomics 2016; 9: 20.

Malik SM, Traub ML. Defining the role of bariatric surgery in polycystic ovarian syndrome patients. World J Diabetes 2012; 3(4): 71−9.

Vrbikova J, Hainer V. Obesity and polycystic ovary syndrome. Obes Facts 2009; 2(1): 26−35.

Pasquali R, Casimirri F, Plate L. Characterization of obese women with reduced sex hormone-binding globulin concentrations. Horm Metab Res 1990; 22(5): 303−6.

Jamal M, Gunay Y, Capper A, Eid A, Heitshusen D, Samuel I. Roux-en-y gastric bypass ameliorates polycystic ovary syn-drome and dramatically improves conception rates: A 9-year analyses. Surg Obes Relat Dis 2012; 8(4): 440−4.

Skubleny D, Switzr NJ, Gill RS, Dykstra M, Shi X, Sagle MA, et.al. The impact of bariatric surgery on polycystic ovary syn-drome: A systemic review and meta analysis. Obes Surg 2016; 26(1): 169−76.

Turkmen S, Andreen L, Cengiz Y. Effects of Roux-en-Y gastric bypass surgery on eating behaviour and allopregnanolone le-vels in obese women with polycystic ovary syndrome. Gynecol Endocrinol 2015; 31(4): 301−5.

Belogolovkin V, Salihu HM, Weldeselasse H, Biroscak BJ, August EM, Mbah AK, et al.. Impact of prior bariatric surgery on ma-ternal and fetal outcomes among obese and non-obese moth-ers. Arch Gynecol Obstet 2012; 285(5): 1211−8.

Kabiru W, Raynor BD. Obstetric outcomes associated with in-crease in BMI category during pregnancy. Am J Obstet Gyne-col 2004; 191(3): 928−32.

Escobar-Morreale HF, Botella-Carretero JI, Alvarez Blasko F, Sancho J, San Millan JL. The polycistic ovary syndrome associated with morbid obesity may resolve after weight loss induced by bariatric sugery. J Clin Endocrinol Metab 2005; 90(12): 6364−9.

Sheiner E, Balaban E, Dreiher J, Levi I, Levy A. Pregnancy out-come in patients fol-lowing different types of bariatric surge-ries. Obes Surg 2009; 19(9): 1286−92.

Pilone V, Hasani A, Di Micco R, Vitiello A, Monda A, Izzo G, et al. Pregnancy after laparoscopic gastric banding: Maternal and neonatal outcomes. Int J Surg 2014; 12(Suppl 1): S136−9.

Bennett WL, Gilson MM, Jamshidi R, Burke AE, Segal JB, Steele KE, et al. Impact of bariatric surgery on hypertensive disorders in pregnancy: retrospective analysis of insurance claims data. BMJ 2010; 340: c1662.

Persson M, Cnattingius S, Wikström AK, Johansson S. Maternal overweight and obesity and risk of pre-eclampsia in women with type 1 diabetes or type 2 diabetes. Diabetologia 2016; 59(10): 2099−105.

World Cancer Research Fund. Food, Nutrition, Physical activity, and the Prevention of Cancer: A global perspective. Washing-ton, DC: American Institute for Cancer Research (AICR); 2007.

Renehan A, Tyson M, Egger M, Heller RF, Zwahlen M. Body-mass index and incidence of cancer: A systematic review and meta-analysis of perspective observational studies. Lancet 2008; 371(9612): 569−78.

Allott EH, Hursting SD. Obesity and cancer: mechanistic in-sights from transdisciplinary studies. Endocr Relat Cancer 2015; 22(6): R365−86.

Blüher M. Adipose tissue dysfunction in obesity. Exp Clin En-docrinol Diabetes 2009; 117(6): 241−50.

Kindel TL, Oleynikov D. The improvement of gastroesophageal reflux disease and Barrett's after bariatric surgery. Obes Surg 2016; 26(4): 718−20.

Mion F, Tolone S, Garros A, Savarino E, Pelascini E, Robert M, et al. High-resolution Impedance Manometry after Sleeve Ga-strectomy: Increased Intragastric Pressure and Reflux are Fre-quent Events. Obes Surg 2016; 26(10): 2449−56.

Sánchez-Pernaute A, Talavera P, Pérez-Aguirre E, Domínguez-Serrano I, Rubio MÁ, Torres A. Technique of Hill's Gastropexy Combined with Sleeve Gastrectomy for Patients with Morbid Obesity and Gastroesophageal Reflux Disease or Hiatal Hernia. Obes Surg 2016; 26(4): 910−2.

Byers T, Sedjo RL. Does intentional weight loss reduce cancer risk? Diabetes Obes Metab 2011; 13(12): 1063−72.

Afshar S, Kelly BS, Seymor K, Lara J, Woodcock S, Mathers JC. The Effects of Bariatric Surgery on Colorectal Cancer Risk: Systematic Review and Meta-analysis. Obes Surg 2014; 24(10): 1793−9.

Sjostrom L. Review of the key results from the Swedish Obese Subjects (SOS) trial - a prospective controlled intervention study of bariatric surgery. J Intern Med 2013; 273(3): 219−34.